Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Acquisitions - Fair Value of Assets and Liabilities Assumed (Details)

Note 3 - Acquisitions - Fair Value of Assets and Liabilities Assumed (Details) - USD ($) $ in Thousands				7 Months Ended	9 Months Ended
	Feb. 01, 2018	Jan. 02, 2018	Sep. 05, 2017	Mar. 31, 2018	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2017
Goodwill				$ 610,667	$ 610,667		$ 579,026
Cash paid, net of cash acquired					65,066	$ 253,941
Goodwill				610,667	610,667		$ 579,026
Trevigen Inc. [Member]
Current assets, net of cash			$ 1,662	1,662	1,662
Adjustments to fair value, current assets, net of cash
Equipment and other long-term assets			154	53	53
Adjustments to fair value, equipment and other long-term assets				(101)
Goodwill			4,595	5,991	5,991
Adjustments to fair value, goodwill				1,396
Total assets acquired			13,511	13,226	13,226
Adjustments to fair value, total assets acquired				(285)
Liabilities			92	387	387
Adjustments to fair value, liabilities				295
Deferred income taxes, net			2,785	2,195	2,195
Adjustments to fair value, deferred income taxes, net				(590)
Net assets acquired			10,634	10,644	10,644
Adjustments to fair value, net assets acquired				10
Cash paid, net of cash acquired			10,634	10,644
Adjustments to fair value, cash paid, net of cash acquired				10
Equipment and other long-term assets			154	53	53
Goodwill			4,595	5,991	5,991
Total assets acquired			13,511	13,226	13,226
Liabilities			92	387	387
Deferred income taxes, net			2,785	2,195	2,195
Trevigen Inc. [Member] \| Developed Technology Rights [Member]
Intangible assets			3,800	5,100	5,100
Adjustments to fair value, intangible assets				1,300
Trevigen Inc. [Member] \| Customer Relationships [Member]
Intangible assets			1,900	260	260
Adjustments to fair value, intangible assets				(1,640)
Trevigen Inc. [Member] \| Trade Names [Member]
Intangible assets			$ 1,400	160	$ 160
Adjustments to fair value, intangible assets				$ (1,240)
Atlanta Biologicals [Member]
Current assets, net of cash		$ 18,678
Equipment and other long-term assets		4,348
Goodwill		21,695
Total assets acquired		56,221
Liabilities		90
Deferred income taxes, net		4,845
Net assets acquired		51,286
Cash paid, net of cash acquired		51,286
Equipment and other long-term assets		4,348
Goodwill		21,695
Total assets acquired		56,221
Liabilities		90
Deferred income taxes, net		4,845
Atlanta Biologicals [Member] \| Developed Technology Rights [Member]
Intangible assets		9,000
Atlanta Biologicals [Member] \| Customer Relationships [Member]
Intangible assets		1,500
Atlanta Biologicals [Member] \| Trade Names [Member]
Intangible assets		$ 1,000
Eurocell Diagnostics, SAS [Member]
Current assets, net of cash	$ 512
Equipment and other long-term assets	188
Goodwill	113
Total assets acquired	7,085
Liabilities	483
Deferred income taxes, net	2,070
Net assets acquired	4,532
Cash paid, net of cash acquired	3,136
Equipment and other long-term assets	188
Goodwill	113
Total assets acquired	7,085
Liabilities	483
Deferred income taxes, net	2,070
Consideration payable	1,396
Eurocell Diagnostics, SAS [Member] \| Customer Relationships [Member]
Intangible assets	$ 6,272